Renee Leck | Director of Investor Relations |
Mark Rothera | President and Chief Executive Officer |
Frank Thomas | Chief Financial Officer |
Bobby Gaspar | Chief Scientific Officer |
Anvita Gupta | Guggenheim |
Gena Wang | Barclays |
Tessa Romero | JPMorgan |
Esther Rajavelu | Oppenheimer |
David Nierengarten | Wedbush |
Yaron Werber | Cowen |
Graig Suvannavejh | Goldman Sachs |
Ladies and gentlemen, thank you for standing by, and welcome to the Orchard Therapeutics Third Quarter 2019 Investor Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions]